北京民康百草医药科技

Beijing Minkang Baicao Pharmaceutical Technology is a professional Contract Research Organization (CRO) based in China, specializing in pharmaceutical R&D and technical services. Founded in 2008, the company provides a comprehensive suite of services including drug synthesis, formulation development, quality research, and consistency evaluation for generic drugs. They are particularly recognized for their expertise in navigating the Chinese regulatory landscape and assisting pharmaceutical manufacturers in achieving bioequivalence for generic products. Minkang Baicao also offers clinical trial management and drug registration services, supporting the entire lifecycle of drug development from preclinical stages to market approval. The company is listed on the National Equities Exchange and Quotations (NEEQ) and operates as a National High-Tech Enterprise in Beijing.